Stay updated on Olezarsen in FCS Adults Post-Volanesorsen: Clinical Trial

Sign up to get notified when there's something new on the Olezarsen in FCS Adults Post-Volanesorsen: Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Olezarsen in FCS Adults Post-Volanesorsen: Clinical Trial page

  1. Check
    today
    No Change Detected
  2. Check
    yesterday
    No Change Detected
  3. Check
    2 days ago
    No Change Detected
  4. Check
    3 days ago
    No Change Detected
  5. Check
    4 days ago
    No Change Detected
  6. Check
    8 days ago
    Change Detected
    Summary
    The value on the webpage has been updated from 2023-08-09 to 2024-05-10, indicating a change in the study details related to Olezarsen (AKCEA-APOCIII-LRX) administered to adults with Familial Chylomicronemia Syndrome (FCS) previously treated with Volanesorsen. This change may be significant for individuals monitoring medical and healthcare-related publications and documentation.
    Difference
    1.0%
    Check dated 2024-05-11T17:10:43.000Z thumbnail image
  7. Check
    18 days ago
    Change Detected
    Difference
    3%
    Check dated 2024-04-30T22:44:10.000Z thumbnail image

Stay in the know with updates to Olezarsen in FCS Adults Post-Volanesorsen: Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Olezarsen in FCS Adults Post-Volanesorsen: Clinical Trial page.